{"id":"https://openalex.org/W2280487143","doi":"https://doi.org/10.1177/1479164115610470","title":"Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus","display_name":"Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-12","ids":{"openalex":"https://openalex.org/W2280487143","doi":"https://doi.org/10.1177/1479164115610470","mag":"2280487143","pmid":"https://pubmed.ncbi.nlm.nih.gov/26567123"},"language":"en","primary_location":{"id":"doi:10.1177/1479164115610470","doi":"https://doi.org/10.1177/1479164115610470","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1479164115610470","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1479164115610470","source":{"id":"https://openalex.org/S115869145","display_name":"Diabetes and Vascular Disease Research","issn_l":"1479-1641","issn":["1479-1641","1752-8984"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes and Vascular Disease Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2280487143"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/1479164115610470","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029568219","display_name":"Diethelm Tsch\u00f6pe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800536013","display_name":"Heart and Diabetes Center North Rhine-Westphalia","ror":"https://ror.org/02wndzd81","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I2800536013"]},{"id":"https://openalex.org/I4210126672","display_name":"Deutsche Diabetes Stiftung","ror":"https://ror.org/03j1c4d98","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4210126672"]},{"id":"https://openalex.org/I4210152922","display_name":"LWL-Universit\u00e4tsklinikum Bochum","ror":"https://ror.org/04nkkrh90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210130751","https://openalex.org/I4210152922"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Diethelm Tsch\u00f6pe","raw_affiliation_strings":["Herz- und Diabeteszentrum Nordrhein-Westfalen, Medizinische Fakult\u00e4t, Universit\u00e4tsklinik der Ruhr Universit\u00e4t Bochum, Bad Oeynhausen, Germany","Stiftung \u2018Der herzkranke Diabetiker\u2019 in der Deutschen Diabetes-Stiftung, Bad Oeynhausen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herz- und Diabeteszentrum Nordrhein-Westfalen, Medizinische Fakult\u00e4t, Universit\u00e4tsklinik der Ruhr Universit\u00e4t Bochum, Bad Oeynhausen, Germany","institution_ids":["https://openalex.org/I2800536013","https://openalex.org/I4210152922","https://openalex.org/I904495901"]},{"raw_affiliation_string":"Stiftung \u2018Der herzkranke Diabetiker\u2019 in der Deutschen Diabetes-Stiftung, Bad Oeynhausen, Germany","institution_ids":["https://openalex.org/I4210126672"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078953106","display_name":"Peter Bramlage","orcid":"https://orcid.org/0000-0003-4970-2110","observed_orcids":["https://orcid.org/0000-0003-4970-2110"]},"institutions":[{"id":"https://openalex.org/I4210092651","display_name":"IPPMed (Germany)","ror":"https://ror.org/00j0wh784","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210092651"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Bramlage","raw_affiliation_strings":["Institut f\u00fcr Pharmakologie und Pr\u00e4ventive Medizin, Mahlow, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmakologie und Pr\u00e4ventive Medizin, Mahlow, Germany","institution_ids":["https://openalex.org/I4210092651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101524054","display_name":"Steffen Schneider","orcid":"https://orcid.org/0000-0003-3256-0726","observed_orcids":["https://orcid.org/0000-0003-3256-0726"]},"institutions":[{"id":"https://openalex.org/I4210114639","display_name":"Stiftung Institut f\u00fcr Herzinfarktforschung","ror":"https://ror.org/0213d4b59","country_code":"DE","type":"other","lineage":["https://openalex.org/I4210114639"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steffen Schneider","raw_affiliation_strings":["Institut f\u00fcr Herzinfarktforschung, Ludwigshafen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Herzinfarktforschung, Ludwigshafen, Germany","institution_ids":["https://openalex.org/I4210114639"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024800057","display_name":"Anselm Kai Gitt","orcid":"https://orcid.org/0000-0003-2573-7239","observed_orcids":["https://orcid.org/0000-0003-2573-7239"]},"institutions":[{"id":"https://openalex.org/I4210114639","display_name":"Stiftung Institut f\u00fcr Herzinfarktforschung","ror":"https://ror.org/0213d4b59","country_code":"DE","type":"other","lineage":["https://openalex.org/I4210114639"]},{"id":"https://openalex.org/I4210130435","display_name":"Klinikum Ludwigshafen","ror":"https://ror.org/037wq4b75","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210130435"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anselm K Gitt","raw_affiliation_strings":["Herzzentrum Ludwigshafen, Medizinische Klinik B, Kardiologie, Ludwigshafen, Germany","Institut f\u00fcr Herzinfarktforschung, Ludwigshafen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herzzentrum Ludwigshafen, Medizinische Klinik B, Kardiologie, Ludwigshafen, Germany","institution_ids":["https://openalex.org/I4210130435"]},{"raw_affiliation_string":"Institut f\u00fcr Herzinfarktforschung, Ludwigshafen, Germany","institution_ids":["https://openalex.org/I4210114639"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5029568219"],"corresponding_institution_ids":["https://openalex.org/I2800536013","https://openalex.org/I4210126672","https://openalex.org/I4210152922","https://openalex.org/I904495901"],"apc_list":{"value":2100,"currency":"USD","value_usd":2100},"apc_paid":null,"fwci":1.1944,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.76660346,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"13","issue":"1","first_page":"2","last_page":"12"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.7217000126838684,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.7217000126838684,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.271699994802475,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hypoglycaemia-incidence","display_name":"hypoglycaemia incidence","score":0.8920000195503235},{"id":"https://openalex.org/keywords/glycemic-variability","display_name":"glycemic variability","score":0.7360000014305115},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8519999980926514},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/macrovascular-events","display_name":"macrovascular events","score":0.9269999861717224},{"id":"https://openalex.org/keywords/antidiabetic-pharmacotherapy","display_name":"antidiabetic pharmacotherapy","score":0.7870000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9612298011779785},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.7653592824935913},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.730869710445404},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6560906171798706},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.48295992612838745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4546310603618622},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.424574613571167},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.37749922275543213},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3556743860244751},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.16880419850349426},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000671","descriptor_name":"Amputation, Surgical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010347","descriptor_name":"Patient Care Planning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D058070","descriptor_name":"Asymptomatic Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060050","descriptor_name":"Angina, Stable","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D065089","descriptor_name":"Glycoside Hydrolase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D065089","descriptor_name":"Glycoside Hydrolase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1479164115610470","doi":"https://doi.org/10.1177/1479164115610470","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1479164115610470","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1479164115610470","source":{"id":"https://openalex.org/S115869145","display_name":"Diabetes and Vascular Disease Research","issn_l":"1479-1641","issn":["1479-1641","1752-8984"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes and Vascular Disease Research","raw_type":"journal-article"},{"id":"pmid:26567123","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26567123","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes & vascular disease research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/1479164115610470","doi":"https://doi.org/10.1177/1479164115610470","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1479164115610470","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1479164115610470","source":{"id":"https://openalex.org/S115869145","display_name":"Diabetes and Vascular Disease Research","issn_l":"1479-1641","issn":["1479-1641","1752-8984"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes and Vascular Disease Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320312328","display_name":"Diabetes-Stiftung","ror":"https://ror.org/02s0rxx79"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2280487143.pdf","grobid_xml":"https://content.openalex.org/works/W2280487143.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1526927233","https://openalex.org/W1592409451","https://openalex.org/W1963542379","https://openalex.org/W1967265218","https://openalex.org/W1968836780","https://openalex.org/W1971532754","https://openalex.org/W1972830106","https://openalex.org/W1993323173","https://openalex.org/W1997074104","https://openalex.org/W1999804954","https://openalex.org/W2004819524","https://openalex.org/W2004870840","https://openalex.org/W2014346836","https://openalex.org/W2015544031","https://openalex.org/W2038895410","https://openalex.org/W2059534220","https://openalex.org/W2063298884","https://openalex.org/W2070647639","https://openalex.org/W2075361652","https://openalex.org/W2076573528","https://openalex.org/W2078241682","https://openalex.org/W2083554831","https://openalex.org/W2085546759","https://openalex.org/W2095150462","https://openalex.org/W2095325552","https://openalex.org/W2097995302","https://openalex.org/W2101481281","https://openalex.org/W2105947262","https://openalex.org/W2107648636","https://openalex.org/W2110140798","https://openalex.org/W2119236121","https://openalex.org/W2121812107","https://openalex.org/W2130302665","https://openalex.org/W2133236380","https://openalex.org/W2138835437","https://openalex.org/W2144394379","https://openalex.org/W2149194615","https://openalex.org/W2150540429","https://openalex.org/W2165832533","https://openalex.org/W2171294019","https://openalex.org/W2337454357","https://openalex.org/W2914907213","https://openalex.org/W4250647894"],"related_works":["https://openalex.org/W1997074104","https://openalex.org/W2312950479","https://openalex.org/W2097995302","https://openalex.org/W4206836489","https://openalex.org/W2162643982","https://openalex.org/W2114417910","https://openalex.org/W2413896585","https://openalex.org/W2109992438","https://openalex.org/W2622553968","https://openalex.org/W2091492686"],"abstract_inverted_index":{"AIMS:":[0],"With":[1],"the":[2,162,166],"intensification":[3],"of":[4,12,45,116,145,152,168],"antidiabetic":[5,153,169],"treatment,":[6],"there":[7],"is":[8],"an":[9],"increasing":[10],"risk":[11,98],"hypoglycaemia.":[13],"We":[14],"aimed":[15],"to":[16],"determine":[17],"incidence,":[18],"characteristics":[19],"and":[20,80,155],"outcomes.":[21],"METHODS:":[22],"Prospective,":[23],"observational,":[24],"multicenter":[25],"cohort":[26],"study.":[27],"The":[28,43],"included":[29],"3810":[30],"patients":[31,63,112,131,146],"with":[32,51,64,90,96,132],"type":[33],"2":[34],"diabetes":[35],"had":[36],"their":[37],"treatment":[38,158],"intensified":[39],"at":[40],"baseline.":[41],"RESULTS:":[42],"incidence":[44],"hypoglycaemia":[46,117],"was":[47,59],"11.4%":[48],"per":[49,56],"year":[50],"4.2":[52],"\u00b1":[53],"4.4":[54],"episodes":[55,115,134],"patient.":[57],"Hypoglycaemia":[58],"more":[60,109,128],"frequent":[61,110,129],"in":[62,130],"high":[65],"blood":[66,156],"glucose":[67,157],"variability.":[68],"Predictors":[69],"were":[70,108,127],"heart":[71],"failure":[72],"(odds":[73,83,99,118,135],"ratio:":[74,84,100,119,136],"1.66;":[75],"95%":[76,86,102,121,138],"confidence":[77,87,103,122,139],"interval:":[78,88,104,123,140],"1.20-2.29)":[79],"insulin":[81],"use":[82],"4.03;":[85],"3.05-5.33),":[89],"dipeptidyl":[91],"peptidase-4":[92],"inhibitors":[93],"being":[94],"associated":[95],"reduced":[97],"0.69;":[101],"0.53-0.89).":[105],"Macrovascular":[106],"events":[107,126],"among":[111],"reporting":[113],"severe":[114],"3.39;":[120],"1.32-8.73).":[124],"Microvascular":[125],"non-severe":[133],"1.92;":[137],"1.49-2.49).":[141],"CONCLUSION:":[142],"Case-by-case":[143],"evaluation":[144],"as":[147,149],"well":[148],"appropriate":[150],"selection":[151],"pharmacotherapy":[154],"goals":[159],"could":[160],"maximize":[161],"benefits":[163],"while":[164],"reducing":[165],"risks":[167],"treatment.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2280487143","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
